NCT05266248

Pilot Study Characterizing the Pharmacokinetic Profile of a Novel Encapsulated Caffeine Beverage in the Fed and Fasted States

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 18 (actual)
• Sponsor: PepsiCo Global R&D · Industry
• Sex: All
• Age: 18 Years – 55 Years
• Healthy volunteers: Accepted

Summary

Pilot study designed to characterize the plasma caffeine pharmacokinetic profile of encapsulated caffeine when consumed in the fasted and fed states.

Conditions

• Pharmacokinetics

Interventions

Type	Name	Description
OTHER	250 mg encapsulated caffeine	Zero calorie 500 ml (16.9 oz) flavored, carbonated energy beverage

Timeline

• Start date: 2022-01-25
• Primary completion: 2022-02-03
• Completion: 2022-02-03
• First posted: 2022-03-04
• Last updated: 2022-03-24

Locations

1 site across 1 country: United States